Gayatri BioOrganics (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Gayatri BioOrganics Limited |
|||
|
Price: ₹6.88 | ||
| 52 Week Low: ₹4.75 52 Week High: ₹9.52 |
|||
| Market Capital: 59.58 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Gayatri BioOrganics Share Price Target For 2024
- 1.1.1: Gayatri BioOrganics Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Gayatri BioOrganics Share Price Target For 2025
- 1.2.1: Gayatri BioOrganics Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Gayatri BioOrganics Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Gayatri BioOrganics Financial Performance
- 3.0.1: Is Gayatri BioOrganics A Good Buy For Long Term?
To predict the Gayatri BioOrganics's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Gayatri BioOrganics Share Price Target For 2024
The line chart displays the monthly closing prices of Gayatri BioOrganics with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Gayatri BioOrganics shares in 2024, see the table below.
Gayatri BioOrganics Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 7.24 (+5.23%) | Price Action: 13 Feb 2024 High |
| 2024 Target 2 | 7.15 (+3.92%) | Price Action: 20 Dec 2024 High |
| 2024 Target 1 | 7.07 (+2.76%) | Price Action: 26 Dec 2024 High |
| Current Price | 6.88 | Gayatri BioOrganics's share price as of 26 Dec 2024 |
| Stop Loss 1 | 6.79 (-1.31%) | Price Action: 25 Nov 2024 High |
| Stop Loss 2 | 6.72 (-2.33%) | Price Action: Sep 2024 High |
| Stop Loss 3 | 6.65 (-3.35%) | Price Action: 13 Feb 2024 Low |
Short-Term Technical Outlook
Current Technical Position: Gayatri BioOrganics is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 25-day moving average at ₹6.75 serves as the nearest technical reference point.
Historical Returns: 3-month: +10.61% | 6-month: +10.97% | 1-year: -24.64%
Gayatri BioOrganics Share Price Target For 2025
The line chart displays the monthly closing prices of Gayatri BioOrganics with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Gayatri BioOrganics shares in 2025, see the table below.
Gayatri BioOrganics Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 10.19 (+48.11%) | Price Action: 27 Sep 2023 Low |
| 2025 Target 2 | 10.08 (+46.51%) | Price Action: 24 Nov 2023 High |
| 2025 Target 1 | 9.96 (+44.76%) | Price Action: 12 Sep 2023 Low |
| Current Price | 6.88 | Gayatri BioOrganics's share price as of 26 Dec 2024 |
| Stop Loss 1 | 6.11 (-11.2%) | Price Action: 01 Jul 2024 Low |
| Stop Loss 2 | 6.04 (-12.21%) | Price Action: 01 Aug 2024 High |
| Stop Loss 3 | 5.97 (-13.23%) | Price Action: Jun 2012 High |
Long-Term Technical Outlook
52-Week Range Analysis: Gayatri BioOrganics is currently trading at 44.7% of its 52-week range (₹4.75 - ₹9.52).
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: -24.64% | 3-year: -56.46% | 5-year: +417.29%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Gayatri BioOrganics Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹6.88 | ||
| 2024 | ₹5.18 | -24.7% | ₹5.59 |
| 2025 | ₹5.14 | -0.77% | ₹5.39 |
| 2026 | ₹4.36 | -15.17% | ₹5.05 |
| 2027 | ₹4.32 | -0.91% | ₹4.38 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Gayatri BioOrganics Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 59.58 Crore | Market valuation of Gayatri BioOrganics's shares. |
| Net Income (TTM) | -68.12 Lakh | Net Profit or Loss after all the expenses over the past twelve months. |
| Debt-to-Equity (D/E) Ratio |
-1.04 | Company's total debt divided by total shareholder equity. |
| Total Debt | 36.36 Crore | Sum of Gayatri BioOrganics's current & long-term financial obligations. |
Is Gayatri BioOrganics A Good Buy For Long Term?
Gayatri BioOrganics, a small-cap stock with a market capitalization of ₹59.58 crore and a substantial debt of ₹36.36 crore (Q1 2024-25), presents a mixed investment picture. While its 5-year return of 97.82% is impressive, the recent performance is concerning, showing a YTD loss of -30.24% and a 12-month loss of -31.95%. The high debt-to-equity ratio raises significant risk. Therefore, considering the current financial situation, Gayatri BioOrganics is not a good buy for the long term. Further investigation into the reasons for the recent losses and the company's debt management strategy is crucial before considering any investment.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
